However, in their study, serum levels of FGF21 was significantly lower in type 2 diabetic patients without retinopathy than the patients with DR and according to the regression model, FGF21 was predictive of increasing DR risk after adjustment for triglycerides levels and disease period. This evidence concerns the gene FGF21 and retinal disorder.